Salvatore Milia Appointed to CLC Board of Directors, Assigned to Lead R&D Efforts for Production of TAAT™
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake...
Year: 2021
Acerus Announces Amendment to Credit Agreement
TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today announced...
MediPharm Labs Expands Wellness Portfolio, Launches Next Generation of Oils with New Unique CBN Rich Formula
MediPharm Labs Expanded family of pharma-quality formulations available in Canada MediPharm Labs Expanded family of pharma-quality formulations available in Canada...
Summit Therapeutics Announces Rights Offering
Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has...
Novadiscovery announces new clinical simulation collaboration with Takeda
Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech...
Bavarian Nordic Announces the Resignation of Tommi Kainu as EVP and Chief Business Officer
COPENHAGEN, Denmark, March 26, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Tommi Kainu, MD, PhD...
UCB SA/NV – Convening notice annual shareholders meeting
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV - Public Limited Liability CompanyAllée de la Recherche...
Design Therapeutics Announces Pricing of Initial Public Offering
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc., a biotechnology company developing a platform of gene targeted...
Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines
SAN DIEGO and TOKYO, March 25, 2021 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics Inc., a biotechnology company developing next generation...
Alignment Healthcare Announces Pricing of Initial Public Offering
ORANGE, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”), a mission-based, tech-enabled Medicare...
Capital Senior Living Corporation Announces Fourth Quarter and Full Year 2020 Earnings Release Date and Conference Call
Provides Business UpdateDALLAS, March 25, 2021 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE: CSU) will issue its fourth quarter and full...
Gain Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares
BETHESDA, Md., March 25, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain”) today announced the closing of its initial public...
Afya Limited Announces Medicinae’s Acquisition
NOVA LIMA, Brazil and MINAS GERAIS, Brazil, March 25, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today...
Priveterra Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing April 1, 2021
FORT LAUDERDALE, Fla., March 25, 2021 (GLOBE NEWSWIRE) -- Priveterra Acquisition Corp. (Nasdaq: PMGMU) (the “Company”) today announced that, commencing...
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Announced updated STS101 development plan featuring a new Phase 3 efficacy trial scheduled to begin enrollment mid-2021 with topline results...
Vor Reports Fiscal Year 2020 Financial Results
IND accepted for VOR33, Vor’s lead eHSC product candidate for treatment of AML Completed initial public offering raising $203.4 million...
Universe Pharmaceuticals INC Announces Closing of Initial Public Offering
Ji’an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...
New Study From Top Institutions Shows Why Temperature Screening for Coronavirus With Non-Contact Infrared Thermometers Does Not Work
WATERTOWN, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Since the start of the coronavirus pandemic more than a year ago,...
Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN DIEGO, March 25, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced...
CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Actively recruiting patients in two global, clinical studies evaluating seladelpar in primary biliary cholangitis (PBC): RESPONSE, a 52-week, randomized, placebo-controlled,...